metyrapone has been researched along with Injuries in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metyrapone was administered orally at a dosage of 65 mg/kg of body weight, every 12 hours." | 1.29 | Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds. ( Daley, CA; Powers, RD; Schick, RO; Zerbe, CA, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Thompson, LH | 1 |
| Zhao, L | 1 |
| Messina, JL | 1 |
| Daley, CA | 1 |
| Zerbe, CA | 1 |
| Schick, RO | 1 |
| Powers, RD | 1 |
2 other studies available for metyrapone and Injuries
| Article | Year |
|---|---|
Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury.
Topics: Acute Disease; Animals; Corticosterone; Fatty Acids, Nonesterified; Hemorrhage; Hormone Antagonists; | 2009 |
Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds.
Topics: Adrenalectomy; Adrenocortical Hyperfunction; Animals; Cat Diseases; Cats; Combined Modality Therapy; | 1993 |